These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1714132

  • 1. [New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].
    Kruis W.
    Z Gastroenterol Verh; 1991 Mar; 26():154-6. PubMed ID: 1714132
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease].
    Hartmann F.
    Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE, Helmstädter V.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908
    [No Abstract] [Full Text] [Related]

  • 8. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid].
    Peskar BM.
    Klin Wochenschr; 1988 Nov 15; 66(22):1147-50. PubMed ID: 2907066
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F, Plauth M.
    Internist (Berl); 1990 Nov 15; 31(11):702-6. PubMed ID: 2289856
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP.
    Dtsch Med Wochenschr; 1992 Oct 16; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B, Martínez-Cuesta MA, Calatayud S, Hinojosa J, Esplugues JV.
    Gastroenterol Hepatol; 1997 Oct 16; 20(6):322-34. PubMed ID: 9296850
    [No Abstract] [Full Text] [Related]

  • 17. [Methotrexate in therapy of chronic inflammatory bowel diseases].
    Schröder O, Stein J.
    Z Gastroenterol; 1996 Jul 16; 34(7):457-8. PubMed ID: 8928541
    [No Abstract] [Full Text] [Related]

  • 18. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL.
    Gastroenterol Clin North Am; 1989 Mar 16; 18(1):35-42. PubMed ID: 2563990
    [Abstract] [Full Text] [Related]

  • 19. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Mar 16; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.